World's Best Scientists 2026 revealed!
Jose R. Conejo-Garcia

Jose R. Conejo-Garcia

D-Index & Metrics

Immunology

D-Index
76
Citations
29108
World Ranking
1866
National Ranking
910

Jose R. Conejo-Garcia publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jose R. Conejo-Garcia sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 279 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jose R. Conejo-Garcia D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jose R. Conejo-Garcia sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 76 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jose R. Conejo-Garcia is affiliated with Duke University in the United States and has extensive research contributions primarily in the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics, and Molecular Biology. Their work spans significant subfields such as Immunology, Oncology, Molecular Biology, Cancer Research, and Radiology, Nuclear Medicine, and Imaging.

Their research topics cover a range of areas focused on cancer and immune system interactions, including:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Immune cells in cancer
  • Monoclonal and Polyclonal Antibodies Research
  • Ovarian cancer diagnosis and treatment

Jose R. Conejo-Garcia has published research in a variety of journals with multiple papers appearing in leading venues such as Cancer Research, Journal of Clinical Oncology, and The Journal of Immunology. They also have a notable presence in Regular and Young Investigator Award Abstracts and bioRxiv (Cold Spring Harbor Laboratory).

Frequent co-authors include:

  • Paulo C. Rodrı́guez
  • Xiaoqing Yu
  • Subir Biswas
  • Carmen M. Anadon
  • Jessica A. Mine

Key recent publications by Jose R. Conejo-Garcia include:

  • "Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial" (2021) published in Nature Medicine
  • "Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma" (2021) published in Blood
  • "IgA transcytosis and antigen recognition govern ovarian cancer immunity" (2021) published in Nature
  • "The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling" (2020) published in Immunity
  • "Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma" (2024) published in Immunity

Best Publications

  • Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

    Tyler J Curiel;George Coukos;Linhua Zou;Xavier Alvarez

  • Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

    Lin Zhang;Jose R. Conejo-Garcia;Dionyssios Katsaros;Phyllis A. Gimotty

  • ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis

    Juan R. Cubillos-Ruiz;Pedro C. Silberman;Melanie R. Rutkowski;Sahil Chopra

  • Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors

    Denarda Dangaj;Marine Bruand;Alizée J. Grimm;Catherine Ronet

  • Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer.

    Evgeniy B. Eruslanov;Pratik S. Bhojnagarwala;Jon G. Quatromoni;Tom Li Stephen

  • Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A.

    Jose R. Conejo-Garcia;Fabian Benencia;Maria Cecilia Courreges;Eugene Kang

  • Origin and Role of a Subset of Tumor-Associated Neutrophils with Antigen-Presenting Cell Features in Early-Stage Human Lung Cancer

    Sunil Singhal;Sunil Singhal;Pratik S. Bhojnagarwala;Shaun O'Brien;Edmund K. Moon

  • Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer.

    Julia Tchou;Yangbing Zhao;Bruce L Levine;Paul J Zhang

  • BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression.

    Hengrui Zhu;Fee Bengsch;Nikolaos Svoronos;Melanie R. Rutkowski

  • IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity

    Minkyung Song;Tito A. Sandoval;Chang-Suk Chae;Sahil Chopra

  • Tumor-intrinsic PD-L1 signals regulate cell growth, pathogenesis and autophagy in ovarian cancer and melanoma

    Curtis A Clark;Harshita Gupta;Gangadhara R. Sareddy;Srilakshmi Pandeswara

  • Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial.

    Benjamin C. Creelan;Chao Wang;Jamie K. Teer;Eric M. Toloza

  • Ovarian cancer progression is controlled by phenotypic changes in dendritic cells

    Uciane K. Scarlett;Melanie R. Rutkowski;Adam M. Rauwerdink;Jennifer Fields

  • Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations

    Curtis H. Kugel;Stephen M. Douglass;Marie R. Webster;Amanpreet Kaur;Amanpreet Kaur

  • Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation

    Melanie R. Rutkowski;Tom L. Stephen;Nikolaos Svoronos;Michael J. Allegrezza

  • Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma

    Michael D. Jain;Hua Zhao;Xuefeng Wang;Reginald Atkins

  • Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity

    Juan R. Cubillos-Ruiz;Xavier Engle;Uciane K. Scarlett;Diana Martinez

  • Isolation and biochemical characterization of LEAP‐2, a novel blood peptide expressed in the liver

    Alexander Krause;Rannar Sillard;Burkhard Kleemeier;Enno Klüver

  • Local hyperthermia treatment of tumors induces CD8+ T cell-mediated resistance against distal and secondary tumors

    Seiko Toraya-Brown;Mee Rie Sheen;Peisheng Zhang;Lei Chen

  • IgA transcytosis and antigen recognition govern ovarian cancer immunity.

    Subir Biswas;Gunjan Mandal;Kyle K. Payne;Carmen M. Anadon

  • Tumor Cell-Independent Estrogen Signaling Drives Disease Progression Through Mobilization of Myeloid-Derived Suppressor Cells

    Nikolaos Svoronos;Alfredo Perales-Puchalt;Michael J. Allegrezza;Melanie R. Rutkowski

  • In situ stimulation of CD40 and Toll-like receptor 3 transforms ovarian cancer-infiltrating dendritic cells from immunosuppressive to immunostimulatory cells.

    Uciane K. Scarlett;Juan R. Cubillos-Ruiz;Yolanda C. Nesbeth;Diana G. Martinez

  • Reprogramming Tumor-Associated Dendritic Cells In Vivo Using miRNA Mimetics Triggers Protective Immunity against Ovarian Cancer

    Juan R. Cubillos-Ruiz;Jason R. Baird;Amelia J. Tesone;Melanie R. Rutkowski

  • Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity

    Eduardo Huarte;Juan R. Cubillos-Ruiz;Yolanda C. Nesbeth;Uciane K. Scarlett

  • Mesothelin, a novel immunotherapy target for triple negative breast cancer

    Julia Tchou;Liang-Chuan Wang;Ben Selven;Hongtao Zhang

Frequent Co-Authors

George Coukos
George Coukos Cornell University
Lin Zhang
Lin Zhang University of Pennsylvania
Rugang Zhang
Rugang Zhang The Wistar Institute
Paulo C. Rodriguez
Paulo C. Rodriguez Moffitt Cancer Center
Andrew V. Kossenkov
Andrew V. Kossenkov The Wistar Institute
Tyler J. Curiel
Tyler J. Curiel The University of Texas at San Antonio
Gabriel A. Rabinovich
Gabriel A. Rabinovich Experimental Medicine and Biology Institute
Scott J. Antonia
Scott J. Antonia Duke University
David W. Speicher
David W. Speicher The Wistar Institute
Wayne W. Hancock
Wayne W. Hancock University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology opens doors to diverse healthcare careers, especially when combined with nursing degrees. Many professionals enhance their qualifications by pursuing a doctorate in nursing salary programs, which offer advanced roles and higher earning potential across states. Understanding salary trends is crucial for planning long-term career goals in the healthcare sector.

For nurses interested in advancing their scope of practice, transitioning from a Family Nurse Practitioner (FNP) to an Acute Care Nurse Practitioner (ACNP) is a popular pathway. Resources on how to fnp to acnp transition provide valuable guidance on education requirements and career benefits.

Accelerated programs also cater to ambitious students wanting to expedite their nursing careers. The accelerated fnp programs offer flexible, online options to earn nurse practitioner degrees more quickly, perfect for those balancing work and study.

Additionally, for individuals without a nursing background, online accelerated nursing programs for non nurses provide a streamlined entry into nursing. These programs help non-nurses gain the skills and credentials needed for a robust healthcare career, complementing immunology expertise.

Best Scientists Citing Jose R. Conejo-Garcia

Trending Scientists

Recently Published Articles